Kadima, Israel

Yael Marantz

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 12.5

ph-index = 5

Forward Citations = 92(Granted Patents)


Location History:

  • Kfar Shmuel, IL (2009 - 2011)
  • Kadma, IL (2013)
  • Kadima, IL (2006 - 2016)

Company Filing History:


Years Active: 2006-2016

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovative Work of Inventor Yael Marantz

Introduction:

Inventor Yael Marantz, based in Kadima, IL, is a prolific inventor with an impressive portfolio of 18 patents to his name. His groundbreaking work has significantly contributed to the fields of pharmaceuticals and biotechnology.

Latest Patents:

Marantz's latest patents include cutting-edge inventions such as adenosine analogs and their uses in treating diseases associated with P2Y receptors. These compounds show promise in treating various conditions like cystic fibrosis, asthma, and gastrointestinal problems induced by cancer treatments. Additionally, his work on substituted arylamine compounds as 5-HT receptor antagonists holds potential in addressing obesity-related disorders and psychological conditions like schizophrenia.

Career Highlights:

Throughout his career, Yael Marantz has made significant contributions to companies such as Epix Pharmaceuticals, Inc., demonstrating his expertise in drug discovery and development. His innovative approach to drug design has paved the way for novel treatment options in various medical fields.

Collaborations:

Marantz has collaborated with esteemed colleagues in his professional journey, including Oren Becker and Sharon Shacham. These collaborations have fostered a dynamic environment for innovation, leading to the successful development of groundbreaking pharmaceutical compounds.

Conclusion:

In conclusion, Yael Marantz stands out as a pioneering inventor whose visionary work has significantly advanced the field of pharmaceuticals. With a strong track record of patenting cutting-edge compounds, Marantz continues to drive innovation and make a lasting impact on the medical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…